SKYE

COM:SKYEBIOSCIENCE

Skye Bioscience

  • Stock

Last Close

5.50

12/11 21:00

Market Cap

163.52M

Beta: -

Volume Today

66.72K

Avg: -

Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical c...Show More

peer of

competitor of